Aspiriant LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Sell |
8,119
-122
| -1% | -$4.69K | 0.01% | 245 |
|
|
2025
Q1 | $319K | Buy |
+8,241
| New | +$319K | 0.01% | 230 |
|
|
2020
Q4 | – | Sell |
-4,960
| Closed | -$233K | – | 213 |
|
|
2020
Q3 | $233K | Buy |
+4,960
| New | +$233K | 0.02% | 198 |
|
|
2018
Q2 | – | Sell |
-5,040
| Closed | -$246K | – | 253 |
|
|
2018
Q1 | $246K | Buy |
+5,040
| New | +$246K | 0.02% | 212 |
|